Dr. rer. nat. Clara Dees



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article ASSESSMENT OF SYSTEMIC SCLEROSIS RELATED MYOCARDIAL FIBROSIS BY 68GA-FAPI-04 PET/CT (2022) Treutlein C, Schmidkonz C, Tascilar K, Chenguiti Fakhouri S, Dees C, Györfi AH, Matei AE, et al. Conference contribution, Abstract of a poster Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation (2021) Györfi AH, Matei AE, Fuchs M, Liang C, Rigau A, Hong X, Zhu H, et al. Journal article ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING (2021) Györfi AH, Matei AE, Fuchs M, Rigau A, Hong X, Honglin Z, Luber M, et al. Conference contribution 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Conference contribution NCOA3 AMPLIFIES PROFIBROTIC TRANSCRIPTIONAL PROGRAMS IN SYSTEMIC SCLEROSIS (2021) Dees C, Pötter S, Fuchs M, Bergmann C, Matei AE, Györfi AH, Soare A, et al. Conference contribution Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease (2021) Zhang Y, Shen L, Dreißigacker K, Zhu H, Trinh MT, Meng X, TRAN MANH C, et al. Journal article X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc) (2021) Bergmann C, Hallenberger L, Chenguiti Fakhouri S, Chenguiti Fakhouri S, Merlevede B, Brandt A, Dees C, et al. Journal article 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Journal article Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis (2020) Chakraborty D, Zhu H, Juengel A, Summa L, Li YN, Matei AE, Zhou X, et al. Journal article